Evidence map›Paper›PMID 38917007›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Modular binder technology by NGS-aided, high-resolution selection in yeast of designed armadillo modules.

Yvonne Stark, Faye Menard, Jeliazko R Jeliazkov, Patrick Ernst, Anupama Chembath, Mohammed Ashraf, Anna V Hine, Andreas Plückthun

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Principles ofbioRxiv : the preprint server for biology · 2026
    Article
  2. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yvonne StarkDepartment of Biochemistry, University of Zürich, Zürich CH-8057, Switzerland.
Faye MenardDepartment of Biochemistry, University of Zürich, Zürich CH-8057, Switzerland.
Jeliazko R JeliazkovDepartment of Biochemistry, University of Zürich, Zürich CH-8057, Switzerland.ORCID 0000-0003-4249-1955
Patrick ErnstDepartment of Biochemistry, University of Zürich, Zürich CH-8057, Switzerland.ORCID 0000-0001-6037-1856
Anupama ChembathCollege of Health and Life Sciences, School of Biosciences, Aston University, Aston Triangle, Birmingham B4 7ET, United Kingdom.ORCID 0000-0002-3684-2029
Mohammed AshrafCollege of Health and Life Sciences, School of Biosciences, Aston University, Aston Triangle, Birmingham B4 7ET, United Kingdom.ORCID 0009-0005-5640-5896
Anna V HineCollege of Health and Life Sciences, School of Biosciences, Aston University, Aston Triangle, Birmingham B4 7ET, United Kingdom.ORCID 0000-0003-4065-831X
Andreas PlückthunDepartment of Biochemistry, University of Zürich, Zürich CH-8057, Switzerland.ORCID 0000-0003-4191-5306

Funding

EC | ERC | HORIZON EUROPE European Research Council (ERC) FET-Open Pre-ARTEC | ERC | HORIZON EUROPE European Research Council (ERC) Transition programme PRe-ART-2TSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) 20B2-1_176535
6 · The paper itself

Abstract

Establishing modular binders as diagnostic detection agents represents a cost- and time-efficient alternative to the commonly used binders that are generated one molecule at a time. In contrast to these conventional approaches, a modular binder can be designed in silico from individual modules to, in principle, recognize any desired linear epitope without going through a selection and hit-validation process, given a set of preexisting, amino acid-specific modules. Designed armadillo repeat proteins (dArmRP) have been developed as modular binder scaffolds, and we report here the generation of highly specific dArmRP modules by yeast surface display selection, performed on a rationally designed dArmRP library. A selection strategy was developed to distinguish the binding difference resulting from a single amino acid mutation in the target peptide. Our reverse-competitor strategy introduced here employs the designated target as a competitor to increase the sensitivity when separating specific from cross-reactive binders that show similar affinities for the target peptide. With this switch in selection focus from affinity to specificity, we found that the enrichment during this specificity sort is indicative of the desired phenotype, regardless of the binder abundance. Hence, deep sequencing of the selection pools allows retrieval of phenotypic hits with only 0.1% abundance in the selectivity sort pool from the next-generation sequencing data alone. In a proof-of-principle study, a binder was created by replacing all corresponding wild-type modules with a newly selected module, yielding a binder with very high affinity for the designated target that has been successfully validated as a detection agent in western blot analysis.

Indexed as

Armadillo Domain ProteinsSaccharomyces cerevisiaeEpitopesHigh-Throughput Nucleotide SequencingPeptide LibraryPeptidesProtein BindingArmadillo Domain ProteinsEpitopesPeptide LibraryPeptidesdesigned armadillo repeat proteinsmodular binder technologynext-generation sequencing (NGS)specificity selectionyeast surface display

Identifiers

PMID38917007
PMCPMC11228518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.